Clinical Trials in Luxembourg — Country Dashboard | 10 EU Studies

Filter these 10 trials by condition, phase, sponsor and more.

Open in Search →

10 Registered trials

4 Recruiting

5 Completed trials

6 Sponsors active

3 Research sites

Phase III

Phase II/III

Phase II

Phase IV

Phase I (FiH)

Phase III: 1 Phase II/III: 1 Phase II: 3 Phase IV: 1 Phase I (FiH): 4

Oversight events in trials active here:

9 temporary halts across 1 trial

View oversight register →

Top conditions

Parkinson's disease 2 Acute coronary syndrome 1 Small cell lung cancer extensive stage 1 Chronic coronary syndrome 1

Top sponsors

Novadip Biosciences 4 Oslo University Hospital HF 2 F. Hoffmann-La Roche AG 1 Fondazione Ricerca e Innovazione Cardiovascolare 1 Intergroupe Francophone De Cancerologie Thoracique 1 Universitaetsklinikum Tuebingen AöR 1

Cities with most trials

All trials

10 total

A randomized, double-blind, placebo-controlled, 104-week proof-of-concept study to evaluate the efficacy of intravenous prasinezumab in part… Pending

2024-513496-40-00 Phase II PARKINSON’S DISEASE Universitaetsklinikum Tuebingen AöR
Study assessing the efficacy of etoposide free chemotherapy plus durvalumab in first line extensive disease Small Cell Lung Cancer Recruiting

2023-504670-38-00 Phase II Extensive disease Small Cell Lung Cancer Intergroupe Francophone de Cancerologie Thoracique
A prospective multicentre single-arm study in adults to evaluate the safety and preliminary efficacy of the autologous 3D osteogenic implant… Recruiting

2024-517762-42-01 Phase I (FiH) recalcitrant lower limb nonunion Novadip Biosciences
Study comparing single versus dual antiplatelet therapy in elderly patients or patients at risk of bleeding undergoing balloon surgery. Recruiting

2024-519706-13-00 Phase IV Patients with Stable or Unstable coronary syndromes who have… Fondazione Ricerca e Innovazione Cardiovascolare
Long-term safety bucket trial with NVDX3, an osteogenic implant of human allogenic origin Recruiting

2024-511661-11-01 Phase I (FiH) Distal Radius fracture Novadip Biosciences
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants with Early Parkinson's Disease Ended

2023-507132-21-00 Phase II/III Early Parkinson's disease F. Hoffmann-La Roche AG
A proof-of-concept study with NVDX3, an osteogenic implant of human allogenic origin, in the treatment of low grade degenerative lumbar spon… Ended

2023-508471-37-00 Phase I (FiH) Low grade degenerative lumbar spondylolisthesis by interbody… Novadip Biosciences
A first-in-human proof-of-concept study with NVDX3, an osteogenic implant of human allogenic origin, in the treatment of distal radius fract… Ended

2023-508321-27-00 Phase I (FiH) Distal radius fractures Novadip Biosciences
Efficacy and Safety of AXL-Inhibitor bemcentinib for the Treatment of Moderate COVID-19 (AXL-SolidAct) Ended

2022-500363-12-00 Phase II SARS CoV-2 (COVID-19) Oslo University Hospital Hf
European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial (SolidAct) Ended

2022-500385-99-00 Phase III SARS-CoV II infection (Coronavirus disease) Oslo University Hospital Hf

Showing 1–10 of 10 trials

← All countries